Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
WinSanTor logo — Working to discover and develop treatments for peripheral ne...

WinSanTor

Working to discover and develop treatments for peripheral neuropathy.

Founded 2011 United States San Diego, United States 12 employees Venture round Total: $782.94K Biotechnology, Health Care

General Information

Company Name WinSanTor
Founded Year 2011
Location United States San Diego, United States
Employees 12
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with WinSanTor. To contact WinSanTor, visit winsantor.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does WinSanTor compare?

A PDF of WinSanTor and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting WinSanTor soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About WinSanTor

WinSanTor Inc. is a clinical-stage biotechnology company founded in 2011, with a clear mission encapsulated in its slogan: "Working to discover and develop treatments for peripheral neuropathy." The company's focus lies in the discovery and development of treatments for peripheral neuropathies, encompassing conditions such as diabetic peripheral neuropathy, chemo-induced peripheral neuropathy, HIV-induced, and others. This forward-thinking approach is backed by a team of scientific and industry experts who are committed to leveraging recent scientific insights into the biological processes underlying degenerative diseases to develop effective medicines. Notably, WinSanTor has attracted Venture Round investment at 12 February 2019, with Christoph Lymbersky as one of the key investors. This investment served to bolster the company's pursuit of a science-driven approach to translational medicine and clinical development. Operating at the intersection of Biotechnology and Health Care industries, WinSanTor's dedication to addressing a critical medical need is underpinned by its commitment to rigorous scientific and clinical development methodologies.

Business keywords: clinical-stage, treatments, peripheral neuropathies, diabetic peripheral neuropathy, chemo-induced peripheral neuropathy, HIV-induced neuropathy, translational medicine, clinical development, science-driven approach, degenerative diseases, medicine discovery, biological processes, neurodegenerative diseases

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Christoph Lymbersky
12 Feb 2019
Venture Round $782.94K -
16 Nov 2017
Series A Undisclosed 1
Thynk Capital
11 Feb 2015

WinSanTor Alternatives & Competitors

View All Alternatives
WinSanTor vs
Redx Pharma
Redx Pharma United Kingdom

Biotech company focusing on the discovery and development of novel targeted medicines to treat cance...

Post-IPO Equity
39 employees
Biotechnology, Health Care
WinSanTor vs
Rapid Nexus Nanotech Wound Solutions, Inc.
Rapid Nexus Nanotech Wound Solutions, Inc. United States

The first company to develop a novel peripheral neuropathy tissue healing product.

6 employees
Biotechnology, Health Care
WinSanTor vs
GENERVON BIOPHARMACEUTICALS LLC
GENERVON BIOPHARMACEUTICALS LLC United States

A clinical-stage biopharmaceutical innovator developing groundbreaking treatments for neurodegenerat...

2 employees
Biotechnology, Health Care
View all alternatives

FAQ About WinSanTor

Working to discover and develop treatments for peripheral neuropathy.
WinSanTor was founded in 2011.
WinSanTor is headquartered in San Diego, United States.
WinSanTor operates in Biotechnology and Health Care. Its work centres on clinical-stage, treatments, peripheral neuropathies and diabetic peripheral neuropathy.
WinSanTor has approximately 12 employees.
WinSanTor has completed 3 funding rounds, raising a total of $782.94K. The latest funding stage is Venture round.
Top alternatives and competitors to WinSanTor include Redx Pharma, Rapid Nexus Nanotech Wound Solutions, Inc., GENERVON BIOPHARMACEUTICALS LLC, PRAEVENTIX LLC, Cognition Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
WinSanTor and Redx Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for WinSanTor, https://bouncewatch.com/company/winsantor, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes